Impfen bei pneumologischen Erkrankungen – was, wann und wie? DOI

Cathrin Kodde,

Leif Erik Sander

DMW - Deutsche Medizinische Wochenschrift, Journal Year: 2024, Volume and Issue: 149(17), P. 1045 - 1049

Published: Aug. 1, 2024

SARS-COV-2 : During the COVID-19 pandemic, mRNA-based vaccines were approved for first time. The mRNA encodes viral spike protein, leading to development of specific antibodies and T-cells, providing effective protection against severe illness death from COVID-19. New variants regularly emerge due rapid evolution. Available can be adapted circulating variants. For upcoming winter season, Omicron sublineage JN.1 have been recommended. SEASONAL INFLUENZA Seasonal influenza viruses change significantly with regard their antigenic properties each necessitating updated vaccines. WHO predicts recommends which genetic should included in vaccine. Quadrivalent recommended previously, but 2024/2025, trivalent are advised as Influenza B/Yamagata lineage has not circulated since 2020. all people over 60 years age, a high-dose vaccine is recommended, showing slightly improved efficacy.

Language: Английский

Welche Botschaften gehen von COVID-19 für die nächste Pandemie aus? DOI

Thomas Hoppen

Pädiatrie, Journal Year: 2024, Volume and Issue: 36(2), P. 28 - 31

Published: April 1, 2024

Citations

0
Pandemie – war da was? Was von Corona aus ärztlicher Sicht zu lernen ist DOI

Werner Hofmann

Springer eBooks, Journal Year: 2024, Volume and Issue: unknown, P. 57 - 67

Published: Jan. 1, 2024

Citations

0
Impfen bei pneumologischen Erkrankungen – was, wann und wie? DOI

Cathrin Kodde,

Leif Erik Sander

DMW - Deutsche Medizinische Wochenschrift, Journal Year: 2024, Volume and Issue: 149(17), P. 1045 - 1049

Published: Aug. 1, 2024

SARS-COV-2 : During the COVID-19 pandemic, mRNA-based vaccines were approved for first time. The mRNA encodes viral spike protein, leading to development of specific antibodies and T-cells, providing effective protection against severe illness death from COVID-19. New variants regularly emerge due rapid evolution. Available can be adapted circulating variants. For upcoming winter season, Omicron sublineage JN.1 have been recommended. SEASONAL INFLUENZA Seasonal influenza viruses change significantly with regard their antigenic properties each necessitating updated vaccines. WHO predicts recommends which genetic should included in vaccine. Quadrivalent recommended previously, but 2024/2025, trivalent are advised as Influenza B/Yamagata lineage has not circulated since 2020. all people over 60 years age, a high-dose vaccine is recommended, showing slightly improved efficacy.

Language: Английский

Citations

0